scholarly journals Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J)

2016 ◽  
Vol 44 (4) ◽  
pp. 355-362 ◽  
Author(s):  
Hidehisa Saeki ◽  
Hidemi Nakagawa ◽  
Ko Nakajo ◽  
Taeko Ishii ◽  
Yoji Morisaki ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Japanese Patients ◽  
Pustular Psoriasis ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 3 ◽  
Severe Plaque Psoriasis ◽  
Generalized Pustular Psoriasis ◽  
Open Label Phase ◽  
Erythrodermic Psoriasis

scholarly journals Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open-label phase 3 study

2018 ◽  
Vol 45 (12) ◽  
pp. 1371-1380 ◽  
Author(s):  
Akimichi Morita ◽  
Fumikazu Yamazaki ◽  
Takashi Matsuyama ◽  
Kenzo Takahashi ◽  
Satoru Arai ◽  
...  
Keyword(s):  
Japanese Patients ◽  
Pustular Psoriasis ◽  
Open Label ◽  
Phase 3 ◽  
Generalized Pustular Psoriasis ◽  
Open Label Phase ◽  
Adalimumab Treatment

scholarly journals Efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis: 24-week results from an open-label phase 3 study (MEASURE 2-J)

2019 ◽  
Vol 30 (1) ◽  
pp. 132-140 ◽  
Author(s):  
Mitsumasa Kishimoto ◽  
Atsuo Taniguchi ◽  
Ayako Fujishige ◽  
Shuhei Kaneko ◽  
Sibylle Haemmerle ◽  
...  
Keyword(s):  
Ankylosing Spondylitis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase

scholarly journals Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

2018 ◽  
Vol 54 (1) ◽  
pp. 87-95 ◽  
Author(s):  
Tetsuo Takehara ◽  
Naoya Sakamoto ◽  
Shuhei Nishiguchi ◽  
Fusao Ikeda ◽  
Tomohide Tatsumi ◽  
...  
Keyword(s):  
Japanese Patients ◽  
Decompensated Cirrhosis ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase

scholarly journals Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1)

2017 ◽  
Vol 44 (11) ◽  
pp. 1285-1290 ◽  
Author(s):  
Shinichi Imafuku ◽  
Hitoe Torisu-Itakura ◽  
Atsushi Nishikawa ◽  
Fangyi Zhao ◽  
Gregory S. Cameron ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Severe Plaque Psoriasis
Sign in / Sign up

Export Citation Format

Share Document